Is a complete FRA/42Z research report available?

No complete published report is available for fra/42Z (FRA/42Z) on this page. Market-directory data, when present, is not a substitute for a reviewed stock analysis.

FRA/42Z (FRA/42Z)

Frankfurt Stock Exchange: FRA/42Z · EUR

€163

-4.10 (-2.5%)· Recorded snapshot

Coverage state: Market snapshot only — no published research

Market snapshot recorded 2026-07-29 02:00 UTC. No published research is attached to this ticker. Prices and fundamentals on this server-rendered page are dated snapshots, not a real-time trading feed.

On-demand research

Generate the first FRA/42Z analysis

Start the full research workflow when this ticker is ready in our data system.

Market cap	35.1B
Net income (ttm)	-1.2B
EPS (ttm)	-€6.18
Volume	0

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -1.2B
EPS (ttm): -€6.18
Market cap: 35.1B

Calendar

Next earnings

Upcoming earnings date and setup when available.

Upcoming

DateLoading

Window—

EPS estimate—

Revenue estimate—

Sector percentile context

All FRA/42Z indicators

Market & fundamental data

Available fields

143

Groups with data

Currency

USD

Showing 143 of 143 available metrics for this ticker.

Profile and market data

Ticker identity, listing, currency, market cap, and source dates.

Metric	Value
Country	United States
Country code	DE
Employees	883
Employees Change	319%
Employees Change Percent	65.1
Enterprise value	EUR 33.9B
Exchange	Frankfurt Stock Exchange
Financial currency	USD
First seen	2026-05-10
Industry	Biological Products, Except Diagnostic Substances
Last refreshed	2026-07-29
Market cap	EUR 35.1B
Price	EUR 163
Price currency	EUR
Sic	2836
Symbol	fra/42Z
Website	https://www.revmed.com

Valuation

Multiples, yields, enterprise-value ratios, and valuation checks.

Metric	Value
Earnings Yield	-3.38%
FCF yield	-2.64%
P/B ratio	27.02x

Profitability

Margins, returns on capital, cash conversion, and quality metrics.

Metric	Value
Gross Profit	EUR -976.2M
Net Income	EUR -1.2B
Profit Per Employee	EUR -1.3M
ROA	-37.53
Roa5y	-21.66
ROCE	-70.61
ROE	-76.67
Roe5y	-39.1
ROIC	-41.78

Growth

Revenue, earnings, cash-flow, and forward growth indicators.

Metric	Value
Cagr1y	431.82%
Cagr3y	93.53%
Cagr5y	46.89%

Financial strength

Debt, cash, solvency, accounting-quality, and balance-sheet signals.

Metric	Value
Assets	EUR 2B
Cash	EUR 1.7B
Current Assets	EUR 1.7B
Current Liabilities	EUR 254.8M
Debt	EUR 379.2M
Debt Equity	EUR 0.29
Debt FCF	EUR -0.41
Equity	EUR 1.3B
Interest Coverage	-38.07
Liabilities	EUR 653.8M
Long Term Assets	EUR 223.1M
Long Term Liabilities	EUR 399M
Net Cash	EUR 1.3B
Net Cash By Market Cap	EUR 3.63
Net Cash Growth	-25.28%
Net Debt Equity	EUR -0.98
Tangible Book Value	EUR 1.2B
Tangible Book Value Per Share	EUR 6.19

Liquidity

Current-asset coverage and working-capital efficiency metrics.

Metric	Value
Current ratio	6.8
Net Working Capital	EUR -184.9M
Quick ratio	6.59
Working Capital	EUR 1.5B

Dividends and buybacks

Dividend yield, payout, buybacks, and shareholder-yield indicators.

Metric	Value
Buyback Yield	-10.96%

Performance and technicals

Returns, volatility, beta, momentum, RSI, and moving-average context.

Metric	Value
1Y total return	431.21%
200-day SMA	97.98
3Y total return	625.22%
50-day SMA	148.3
50-day SMA vs 200-day SMA	50over200
5Y total return	583.61%
All Time High	175.3
All Time High Change	-4.82%
All Time High Date	2026-07-03
All Time Low	13.8
All Time Low Change	1,108.7%
All Time Low Date	2022-05-12
ATR	5.31
Ch YTD	147.1
High	167.8
High52	175.3
High52 Date	2026-07-03
High52ch	-7.16%
Low	162.7
Low52	29.6
Low52 Date	2025-08-12
Low52ch	449.66%
Ma50ch	12.47%
Price vs 200-day SMA	70.24%
RSI	58.05
RSI Monthly	89.04
RSI Weekly	72.11
Sharpe ratio	2.51x
Sortino ratio	5.89
Total Return	-10.96%
Tr YTD	147.1
Tr1m	4.58%
Tr1w	8.77%
Tr3m	45.8%

Analyst estimates

Ratings, targets, revisions, and forward estimate fields.

Metric	Value
Operating Income	EUR -1.2B

Ownership and float

Institutional, insider, float, short-interest, and share-count fields.

Metric	Value
Float	194,110,848%
Shares Insiders	2.26%
Shares Institutions	87.76%
Shares Qo Q	0.73%
Shares Yo Y	10.96%
Short Ratio	5.02

Other indicators

Additional ticker metrics that do not fit the primary research groupings yet.

Metric	Value
Adjusted FCF	EUR -1.1B
Adjusted OCF	-1,073,782,447
Average Volume	125.25x
Bv Per Share	6.5
CAPEX	EUR -12.4M
Ch1m	4.58
Ch1w	8.77
Ch1y	431.2
Ch3m	45.8
Ch3y	625.2
Ch5y	583.6
Ch6m	102.2
Change	-2.46%
Change From Open	-2.31
Close	166.8
Days Gap	-0.15
Depreciation Amortization	7,423,741.6
Earnings Date	2026-08-07
EBIT	EUR -1.2B
EBITDA	EUR -1.2B
EPS	EUR -6.18
F Score	1
FCF	EUR -929.5M
FCF EV Yield	-2.75x
Financing CF	745,352,416
Fiscal Year End	December
Founded	2,014
Goodwill	12,853,623
Investing CF	265,933,261
Is Primary Listing	0
Last Earnings Date	2026-05-06
Last Report Date	2026-03-31
Ma150	112
Ma150ch	48.98%
Ma20	164.1
Ma20ch	1.65%
Net CF	94,141,079
Next Earnings Date	2026-08-07
Open	166.6
Position In Range	0
Ppne	141,989,947.1
Price Date	2026-07-28
Ptbv Ratio	28.35
Relative Volume	0.02x
Share Based Comp	156,637,849
Tr6m	102.18%
Volume	0

FRA/42Z (FRA/42Z)

Coverage state: Market snapshot only — no published research

Generate the first FRA/42Z analysis

Price

Financial snapshot

Fair-value bridge

Latest news · FRA/42Z

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All FRA/42Z indicators

Profile and market data

Valuation

Profitability

Growth

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Analyst estimates

Ownership and float

Other indicators

Deeper analysis on FRA/42Z

Frequently asked questions